LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
67.09 17.25 524 5221 0.1004 0.5132
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
67.09 17.25 7781 5221 1.4903 1.0992
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
69.06 17.25 1815 5242 0.3462 0.7586
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
69.06 17.25 7632 5242 1.4558 1.0932
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
69.06 17.25 396 5242 0.0755 0.4622
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
69.06 17.25 8235 5242 1.5708 1.1126
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
71.03 17.25 1607 5367 0.2994 0.7290
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
71.03 17.25 8037 5367 1.4975 1.0999
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
71.03 17.25 462 5367 0.0861 0.4874
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
71.03 17.25 8602 5367 1.6027 1.1172
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
73.00 17.25 1437 5546 0.2591 0.7006
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
73.00 17.25 8401 5546 1.5146 1.1022
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
73.00 17.25 456 5546 0.0822 0.4817
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
73.00 17.25 8908 5546 1.6060 1.1171
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
74.97 17.25 1531 5618 0.2725 0.7115
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
74.97 17.25 8742 5618 1.5558 1.1088
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
74.97 17.25 547 5618 0.0974 0.5130
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
74.97 17.25 9248 5618 1.6459 1.1230
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
76.94 17.25 1459 5681 0.2568 0.6999
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
76.94 17.25 9103 5681 1.6022 1.1160
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
76.94 17.25 523 5681 0.0921 0.5037
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
76.94 17.25 9599 5681 1.6895 1.1294
MN20160310_N02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
78.91 17.25 1422 5730 0.2481 0.6934
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
78.91 17.25 9413 5730 1.6426 1.1221
MN20160310_N02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
78.91 17.25 415 5730 0.0724 0.4619
MN20160310_N02
D18